Silymarin reduces hyperinsulinemia, malondialdehyde levels, and daily insulin need in cirrhotic diabetic patients

Authors
Category Primary study
JournalCurrent Therapeutic Research - Clinical and Experimental
Year 1993
This article has no abstract
Epistemonikos ID: e3dcd310f8aa8aac0883d767a9ab48bbde83ec8c
First added on: Feb 03, 2025